BioSpace News Archive

Drug Development

Beyond Air® Announces Positive Preclinical Data on Role of Nitric Oxide in Autism Spectrum Disorder (ASD)

Beyond Air, Inc. announced the presentation of data that support the ongoing preclinical development of selective neuronal nitric oxide synthase inhibibitors for the treatment of Autism Spectrum Disorder.

August 7, 2023
·
9 min read
Biotech Beach

Cardiff Oncology Announces New Lead Program in First-Line Metastatic Colorectal Cancer and Expanded Pfizer Relationship

Cardiff Oncology, Inc. (Nasdaq: CRDF) today announced plans to advance the company’s lead program to the first-line setting of metastatic colorectal cancer (mCRC) and conduct its new CRDF-004 trial with study execution support from Pfizer Ignite, a new end-to-end service for biotech companies.

August 7, 2023
·
8 min read
Business

BrainStorm to Announce Second Quarter 2023 Financial Results and Provide a Corporate Update

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI) announced today that it will hold a conference call to update shareholders on financial results for the second quarter ended June 30, 2023, and provide a corporate update, at 8:00 a.m. Eastern Time on Monday, August 14th.

August 7, 2023
·
4 min read
FDA

Food and Drug Administration Approves First Postpartum Depression Pill, Research Led by Northwell Health’s Feinstein Institutes

In a landmark decision, the U.S. Food and Drug Administration has approved the first at-home oral pill, zuranolone, which will be sold under the brand named Zurzuvae, for treating perinatal or postpartum depression – a condition one in eight birthing women experience.

August 7, 2023
·
4 min read
Business

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter with Conference Call and Webcast Today at 4:30 p.m. ET

Enanta Pharmaceuticals, Inc., a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections, reported financial results for its fiscal third quarter ended June 30, 2023.

August 7, 2023
·
13 min read
Business

Biodesix Announces Second Quarter 2023 Results and Highlights

Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced its financial and operating results for the second quarter ended June 30, 2023 and provided a corporate update.

August 7, 2023
·
11 min read
Business

AnaptysBio Announces Second Quarter 2023 Financial Results and Provides Business Update

AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today reported operating results for the second quarter ended June 30, 2023 and provided a business update.

August 7, 2023
·
11 min read
Business

SI-BONE, Inc. Reports Financial Results for the Second Quarter 2023 and Increases Annual GuidanceAnnual guidance increased to $132 million - $134 million, implying annual growth of 24%-26%

SI-BONE, Inc., a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, reported financial results for the quarter ended June 30, 2023.

August 7, 2023
·
9 min read
Business

Diane M. Bryant Joins Haemonetics’ Board of Directors

Haemonetics Corporation, a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, has announced the election of Diane M. Bryant to its Board of Directors.

August 7, 2023
·
2 min read
Business

ACELYRIN, INC. to Present Second Quarter 2023 Financial Results and Corporate Update on August 14, 2023

ACELYRIN, INC. announced it will host a conference call on Monday, August 14, 2023 at 4:30 p.m. ET to discuss its second quarter 2023 financial results and provide a corporate update.

August 7, 2023
·
2 min read